Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

D-Cycloserine does not affect social withdrawal in autistic children

Jan. 9, 2008

Jazz Pharmaceuticals receives orphan drug designation for acute repetitive seizures candidate

Jan. 8, 2008

Biogen and Elan report on Tysabri safety in MS patients

Jan. 8, 2008

Pfizer and Taisho sign definitive agreement for novel schizophrenia drug candidate

Jan. 8, 2008

Recent patents disclose new psychopharmacologic drugs

Jan. 8, 2008

Multifunctional serotonin receptor modulator suppresses psychosis and appetite in mice

Jan. 8, 2008

Innocoll initiates dosing in U.S. phase II clinical trial of CollaRx bupivacaine surgical implant

Jan. 8, 2008

Link between metabotropic glutamate receptor and fragile X syndrome seen in mice

Jan. 8, 2008

Significant treatment effect seen with gepirone ER in depression studies

Jan. 8, 2008

FDA grants orphan drug designation to Ovation's clobazam for Lennox-Gastaut syndrome

Jan. 7, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...